Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Market Capitalization	6,242	5,239	3,104	3,261	8,144	1,692
Market Cap Growth	152.10%	68.80%	-4.84%	-59.96%	381.32%	-17.32%
Enterprise Value	6,516	6,325	4,110	3,952	8,399	1,846
Last Close Price	40.16	33.71	19.97	21.26	53.09	11.03
PS Ratio	12.41	10.14	4.78	6.43	24.69	4.66
PB Ratio	87.77	80.69	-126.49	7.88	13.59	2.34
P/TBV Ratio	128.10	124.44	-	15.00	14.43	2.50
P/FCF Ratio	-	-	189.81	-	-	-
P/OCF Ratio	-	-	21.95	-	-	48.11
EV/Sales Ratio	12.95	12.24	6.33	7.80	25.46	5.08
EV/EBITDA Ratio	136.61	557.77	-	-	-	92.74
EV/FCF Ratio	-40.70	-	251.38	-	-	-
Debt / Equity Ratio	5.18	7.82	-38.70	2.62	0.66	0.45
Debt / EBITDA Ratio	7.51	35.37	-	-	-	16.07
Debt / FCF Ratio	-	-	58.08	-	-	-
Net Debt / Equity Ratio	3.83	6.96	-37.69	2.42	0.62	0.31
Net Debt / EBITDA Ratio	5.92	39.85	-8.12	-8.17	-7.07	11.24
Net Debt / FCF Ratio	-1.70	-2.92	56.56	-1.54	-2.54	-0.69
Asset Turnover	0.45	0.46	0.38	0.32	0.26	0.33
Inventory Turnover	5.03	5.24	5.08	4.21	5.08	5.43
Quick Ratio	0.38	0.18	0.10	0.29	0.18	0.42
Current Ratio	0.58	0.35	0.17	0.51	1.04	0.58
Return on Equity (ROE)	-1189.13%	-689.73%	-228.96%	-43.93%	-18.57%	-3.55%
Return on Assets (ROA)	-2.72%	-4.66%	-7.62%	-7.49%	-5.84%	-0.78%
Return on Invested Capital (ROIC)	-11.22%	-11.78%	-18.19%	-16.08%	-12.18%	-1.74%
Return on Capital Employed (ROCE)	-13.60%	-55.10%	-84.70%	-18.60%	-15.50%	-1.60%
Earnings Yield	-1.66%	-2.66%	-14.33%	-6.80%	-1.50%	-1.54%
FCF Yield	-2.56%	-2.96%	0.53%	-19.97%	-1.80%	-19.03%
Buyback Yield / Dilution	0.54%	0.52%	-0.98%	0.20%	-0.75%	0.72%
Total Shareholder Return	0.54%	0.52%	-0.98%	0.20%	-0.75%	0.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.